EUVIMEDObjevte EUVIMED
Crossref

Engineered Probiotics-Based Biohybrid-Driven Tumor Metabolic Remodeling To Boost Tumor Photoimmunotherapy

Qinglian Hu iD, Xiaoyu Huang, Tong Wang, Zhuoting Lu, Dongchang Sun iD, Yuanxiang Jin iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c02850 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2025. Written by Qinglian Hu and 5 co-authors. Institution: College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China. Major MEDLINE topics: Probiotics, Immunotherapy, Colorectal Neoplasms, Phototherapy. Cited 11 times so far (Crossref); 45 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Bioengineered probiotics enable new opportunities to address abnormal cancer metabolism and suppressive immune-environment interactions for improved therapeutic susceptibility. Here, Escherichia coli Nissle 1917 (EcN) was constructed to convert ammonia into l-arginine continuously and was further modified with polydopamine (PDA) to form living biotherapeutic argEcN@P for enhanced colorectal cancer eradication. Benefiting from the movement of EcN, argEcN@P could colonize and penetrate deep in tumors through hypoxia targeting and increase the intratumoral l-arginine concentrations. Upon near-infrared light (NIR) irradiation, heating induced by PDA could ablate tumor cells efficiently and release tumor antigens, which induce immunogenic cell death (ICD). More interestingly, argEcN@P remarkably promotes differentiation into M1-like macrophages in tumor tissues, inhibiting primary, distant tumor growth by inducing potent adaptive antitumor immunity. More importantly, argEcN@P treatment efficiently prevented postoperative tumor recurrence by inducing long-term immune memory. Taken together, this platform based on bioengineered probiotics provides a promising strategy for tumor metabolic reprogramming sensitized photothermal immunotherapy in deep tumors.

Subjects

MeSH terms (MEDLINE)

ProbioticsImmunotherapyColorectal NeoplasmsPhototherapyAnimalsMiceHumansPolymersIndolesEscherichia coliArginineCell Line, TumorMice, Inbred BALB CInfrared Rays

Author keywords

engineered probioticsmetabolic reprogrammingphotoimmunotherapypolydopaminesynthetic biology

Substances

polydopaminePolymersIndolesArginine

Authors and institutions

  • College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China.

ORCID profiles: Qinglian Hu, Dongchang Sun, Yuanxiang Jin

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province

Cite

APA

Hu, Q., Huang, X., Wang, T., Lu, Z., Sun, D., & Jin, Y. (2025). Engineered Probiotics-Based Biohybrid-Driven Tumor Metabolic Remodeling To Boost Tumor Photoimmunotherapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c02850

Vancouver

Hu Q, Huang X, Wang T, Lu Z, Sun D, Jin Y. Engineered Probiotics-Based Biohybrid-Driven Tumor Metabolic Remodeling To Boost Tumor Photoimmunotherapy. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c02850

BibTeX
@article{Hu2025,
  author = {Hu, Qinglian and Huang, Xiaoyu and Wang, Tong and Lu, Zhuoting and Sun, Dongchang and Jin, Yuanxiang},
  title = {Engineered Probiotics-Based Biohybrid-Driven Tumor Metabolic Remodeling To Boost Tumor Photoimmunotherapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c02850}
}
Start for free →